NM_018398.3:c.316G>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018398.3(CACNA2D3):c.316G>A(p.Val106Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000895 in 1,542,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018398.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152242Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000267 AC: 43AN: 160800Hom.: 0 AF XY: 0.000307 AC XY: 26AN XY: 84636
GnomAD4 exome AF: 0.0000856 AC: 119AN: 1389820Hom.: 0 Cov.: 26 AF XY: 0.0000917 AC XY: 63AN XY: 686736
GnomAD4 genome AF: 0.000125 AC: 19AN: 152360Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74508
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.316G>A (p.V106I) alteration is located in exon 3 (coding exon 3) of the CACNA2D3 gene. This alteration results from a G to A substitution at nucleotide position 316, causing the valine (V) at amino acid position 106 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at